Skip to main content

Prescription medicine

Coral snake immune globulin antivenin

Coral snake immune globulin antivenin is a prescription medicine. No generic is listed in FDA's NDC Directory.

  • No generic listed

Check it at the source: the coral snake immune globulin antivenin FDA label on DailyMed (effective November 22, 2022); every coral snake immune globulin antivenin label on DailyMed.

Highlights of the record

FDA label of November 22, 2022; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026

Used for

From the label: indications and usage

North American Coral Snake Antivenin (Equine) is indicated only for the treatment of envenomation caused by bites of North American coral snakes - Micrurus (including the eastern and Texas varieties).

Forms and strengths

  • 10ml

Injection (powder) for solution.

On the market

Generic approvals
No generic approved
Labelers listed (NDC)
1 of which 0 under generic applications, 1 under brand applications, repackagers included

Supply and safety

Pharmacy cost (NADAC)
Not in the survey
Shortage (FDA)
No current entry
Recalls by its makers (FDA)
No recall recorded

What is coral snake immune globulin antivenin used for?

From the label: indications and usage

North American Coral Snake Antivenin (Equine) is indicated only for the treatment of envenomation caused by bites of North American coral snakes - Micrurus (including the eastern and Texas varieties). North American Coral Snake Antivenin (Equine) is a horse-derived antivenin indicated for the treatment of envenomation caused by North American coral snakes - Micrurus.

Source: FDA drug label (North American Coral Snake Antivenin (Equine)), Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., effective November 22, 2022 (SPL set 6d0f94b4-82ca-37c7-edb0-4f0702cf6c8d), via openFDA; the full label on DailyMed

Is there a generic for coral snake immune globulin antivenin?

No generic coral snake immune globulin antivenin is approved (Drugs@FDA, October 8, 2026).

Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)

What does the coral snake immune globulin antivenin label say about other medicines?

The coral snake immune globulin antivenin label names 2 other medicines in its interaction, contraindication or warning sections. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.

Medicine namedSectionWhat the label says
Albuterolwarnings and precautionsConsider the following precautions to manage hypersensitivity reactions: Emergency medical care (e.g., epinephrine, intravenous antihistamines and/or albuterol) should be readily available.
Epinephrinewarnings and precautionsConsider the following precautions to manage hypersensitivity reactions: Emergency medical care (e.g., epinephrine, intravenous antihistamines and/or albuterol) should be readily available.

Check coral snake immune globulin antivenin against other medicines

Source: FDA drug label (North American Coral Snake Antivenin (Equine)), Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., effective November 22, 2022 (SPL set 6d0f94b4-82ca-37c7-edb0-4f0702cf6c8d), via openFDA; the full label on DailyMed

What next?

Check an interaction
what two or more labels say about each other